<DOC>
	<DOCNO>NCT02149602</DOCNO>
	<brief_summary>This study phase II trial design test feasibility deliver IMRT head neck cancer patient tumours arise midline ( oropharynx hypopharynx ) , assess possible improvement reduce incidence xerostomia bilateral superficial lobe parotid spar IMRT .</brief_summary>
	<brief_title>A Phase II Study Parotid-gland Sparing IMRT Patients With Midline Tumour Head Neck</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms , Squamous Cell</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>histologically confirm locally advanced HNSCC arise oropharynx hypopharynx high risk bilateral parapharyngeal space involvement Patients &lt; 18 year old previous malignancy nonmelanomatous skin cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>involvement bilateral parapharyngeal space</keyword>
</DOC>